Aquestive Therapeutics (AQST) Intangibles (2017 - 2024)

Aquestive Therapeutics' Intangibles history runs 8 years deep, the most recent figure standing at $1.2 million for Q1 2024.

• In Q1 2024, Intangibles fell 11.25% year-over-year to $1.2 million; the TTM figure through Mar 2024 stood at $1.2 million (down 11.25% YoY), while the FY2023 annual figure was $1.3 million, down 10.94% from the prior year.
• Intangibles was $1.2 million for Q1 2024 at Aquestive Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $1.5 million in Q3 2022 to a low of $25000.0 in Q2 2022.
• Historically, Intangibles has averaged $624941.2 across 5 years, with a median of $127000.0 in 2020.
• The sharpest annual moves came in 2020 and 2023: Intangibles tumbled 96.44% in 2020, then jumped 5328.0% in 2023.
• A 5-year view of Intangibles shows it stood at $102000.0 in 2020, then tumbled by 50.0% to $51000.0 in 2021, then surged by 2713.73% to $1.4 million in 2022, then slipped by 10.94% to $1.3 million in 2023, then slipped by 3.05% to $1.2 million in 2024.
• The last three Intangibles figures came in at $1.2 million (Q1 2024), $1.3 million (Q4 2023), and $1.3 million (Q3 2023), per Business Quant data.